-
The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines
- Back
Document Title
The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines
Author
Yang J. Boer J.C. Khongkow M. Phunpee S. Khalil Z.G. Bashiri S. Deceneux C. Goodchild G. Hussein W.M. Capon R.J. Ruktanonchai U. Plebanski M. Toth I. Skwarczynski M.
Affiliations
School of Chemistry and Molecular Biosciences The University of Queensland St. Lucia QLD 4072 Australia; School of Health and Biomedical Sciences RMIT University Bundoora Melbourne VIC 3083 Australia; National Nanotechnology Center (NANOTEC) National Science and Technology Development Agency (NSTDA) 111 Thailand Science Park Phahonyothin Road Klong 1 Pathumthani12120 Thailand; Institute for Molecular Bioscience The University of Queensland St. Lucia QLD 4072 Australia; School of Pharmacy The University of Queensland Woolloongabba QLD 4102 Australia
Type
Article
Source Title
Vaccines
ISSN
2076393X
Year
2023
Volume
11
Issue
2
Open Access
All Open Access Gold Green
Publisher
MDPI
DOI
10.3390/vaccines11020305
Abstract
Intranasal vaccine administration can overcome the disadvantages of injectable vaccines and present greater efficiency for mass immunization. However the development of intranasal vaccines is challenged by poor mucosal immunogenicity of antigens and the limited availability of mucosal adjuvants. Here we examined a number of self-adjuvanting liposomal systems for intranasal delivery of lipopeptide vaccine against group A Streptococcus (GAS). Among them two liposome formulations bearing lipidated cell-penetrating peptide KALA and a new lipidated chitosan derivative (oleoyl-quaternized chitosan OTMC) stimulated high systemic antibody titers in outbred mice. The antibodies were fully functional and were able to kill GAS bacteria. Importantly OTMC was far more effective at stimulating antibody production than the classical immune-stimulating trimethyl chitosan formulation. In a simple physical mixture OTMC also enhanced the immune responses of the tested vaccine without the need for a liposome delivery system. The adjuvanting capacity of OTMC was further confirmed by its ability to stimulate cytokine production by dendritic cells. Thus we discovered a new immune stimulant with promising properties for mucosal vaccine development. ? 2023 by the authors.
Industrial Classification
Knowledge Taxonomy Level 1
Knowledge Taxonomy Level 2
Knowledge Taxonomy Level 3
License
CC BY
Rights
Authors
Publication Source
Scopus